Medindia

X

Nepstar Chain Drugstore (NPD) Greenshoe Fully Exercised

Friday, November 16, 2007 General News J E 4
Advertisement
SHENZHEN, China, Nov. 15 China NepstarChain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or "the Company"), the largestretail drugstore chain in China based on the number of directly operatedstores, announced today that the underwriters of the Company's initial publicoffering ("IPO") have exercised their greenshoe option in full to purchase3,093,750 American Depositary Shares ("ADSs") from the Company at the IPOprice of US$16.20 per ADS less the underwriting discount. The option wasgranted in connection with the Company's IPO, which was priced on November 8,2007.

Including proceeds from the exercise of the greenshoe option, grossproceeds from the Company's IPO would increase to approximatelyUS$384.2million.

Jiannong Qian, Nepstar's Chief Executive Officer, said: "We are delightedthat investors have received our ADSs warmly. The funds raised from our IPOwill enable us to further expand our store network and take other measures toreinforce our leading position in China's retail drugstore industry."

Goldman Sachs (Asia) L.L.C. was the sole global coordinator of theoffering. Goldman Sachs (Asia) L.L.C. and Merrill Lynch, Pierce, Fenner &Smith Incorporated were the joint bookrunners. CLSA Limited was a co-managerof the offering.

Nepstar's registration statement relating to these securities has beendeclared effective by the United States Securities and Exchange Commission.This news release does not constitute an offer to sell or a solicitation of anoffer to buy the securities described herein, nor shall there be any sale ofthese securities in any state or jurisdiction in which such an offer,solicitation or sale would be unlawful prior to registration or qualificationunder the securities laws of any such state or jurisdiction.

The offering of the securities is made only by means of a prospectusforming a part of the effective registration statement. A copy of theprospectus relating to the offering may be obtained by contacting GoldmanSachs & Co. by mail, Attn: Prospectus Department, 85 Broad Street, New York,NY 10004, facsimile: +1-212-902-9316, email: prospectus-ny@ny.email.gs.com.For more information, please contact: In Shenzhen: Lucia Qian China Nepstar Drugstore Chain Ltd Tel: +86-755-2641-4065 Email: qianrt@nepstar.cn In New York: Ivette Almeida The Global Consulting Group Tel: +1-646-284-9455 Email: ialmeida@hfgcg.com In Hong Kong: Bruce Shu Citigate Dewe Rogerson Tel: +852-2533-4607 Email: bruce.shu@citigate.com.hk

SOURCE China Nepstar Chain Drugstore Ltd.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Center For Excellence to Fund Analysis of Michigan...
S
BioHorizons Introduces Its New Tapered Internal Im...